VIVUS, Inc. (VVUS) Says Erectile Dysfunction Trial Meets Goals
11/19/2009
More...
|
Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Cholesterol Drug Meets All Goals of Key Trial
11/17/2009
More...
|
Boehringer Ingelheim Corporation (JOBS) Drug Shown to Kindle Female Sex Drive
11/16/2009
More...
|
AstraZeneca PLC (AZN): Ticagrelor (BRILINTA(TM)) Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting
11/16/2009
More...
|
Merck & Co., Inc. (MRK) Expresses Confidence in the Efficacy and Safety Profiles of ZETIA(R) (ezetimibe) and VYTORIN(R) (ezetimibe/simvastatin) as Effective Medicines for Managing Elevated Cholesterol
11/16/2009
More...
|
The Medicines Company (MDCO)'s Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patient Outcomes Following PCI
11/16/2009
More...
|
Mixed Data for AstraZeneca PLC (AZN) (JOBS) and Bristol-Myers Squibb Company (BMY) (JOBS) Diabetes Drug in New Phase III Study
10/23/2009
More...
|
Human Genome Sciences, Inc. (HGSI) (JOBS), GlaxoSmithKline (GSK) Report Progress With Lupus Treatment
10/22/2009
More...
|
CombinatoRx, Incorporated (CRXX)'s Synavive (CRx-102) Maintains Efficacy Throughout 12 Month Phase 2 Knee OA Extension Trial
10/21/2009
More...
|
Protalix Biotherapeutics's Gaucher Drug Meets Goal in Late-Stage Study
10/16/2009
More...
|
Amicus Therapeutics, Inc. (FOLD)' (JOBS) Gaucher Drug Fails in Mid-Stage Trial
10/5/2009
More...
|
Two Phase III Studies of Genentech (South SF) (DNA)'s Lucentis Show Early and Sustained Improvement in Vision in Patients with Retinal Vein Occlusion
10/5/2009
More...
|
Sanofi-Aventis (France) (SASY.PA), VaxGen, Inc. (VXGN) HIV Vaccine Shows Promise for First Time, Study Shows
9/24/2009
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Weight-Loss Trial Met Goals
9/21/2009
More...
|
Novartis AG (JOBS) Lung Drug Beneficial in Late Stage Study
9/16/2009
More...
|
Complete Genomics, Inc. (JOBS) of Mountain View Deciphers 14 Human Genomes for $4K
9/10/2009
More...
|
VIVUS, Inc. (VVUS) Surges After Diet Drug Meets US Weight-Loss Standards
9/10/2009
More...
|
Eli Lilly and Company (LLY) (JOBS) Halts Development of Arzoxifene for Bone Loss
8/20/2009
More...
|
Genmab A/S (GEN.CO), GlaxoSmithKline (GSK) (JOBS) Cancer Drug Arzerra Disappoints in Phase 3 Study
8/20/2009
More...
|
Amgen (AMGN)'s (JOBS) Vectibix Cancer Drug Shows Mixed Results; Drug Failed Primary Goal But Met Another Primary Goal; Vectibix Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer
8/19/2009
More...
|
Human Genome Sciences, Inc. (HGSI) Achieves Lupus Drug Goals With DSG's EDC
8/18/2009
More...
|
Protalix Biotherapeutics's Gaucher Drug Treatment Protocol Gets FDA Nod
8/17/2009
More...
|
AVANIR Pharmaceuticals (AVNR) Phase 3 Drug Meets Main Study Goal; Stock Soars
8/12/2009
More...
|
Shire Pharmaceuticals Group plc (SHPGY)'s New Gaucher Drug Moves Closer to Market Following Positive Phase III Trial Results
8/3/2009
More...
|
Genentech, Inc. (DNA) Release: Xeloda(R)-Oxaliplatin Combination (XELOX) Shown to Be More Effective Than Standard Chemotherapy Regimen in Adjuvant Colon Cancer
7/20/2009
More...
|
New Data from OSI Pharmaceuticals, Inc. (OSIP) (JOBS), Genentech, Inc. (Oceanside) (DNA) (JOBS) Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
7/13/2009
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Obesity Product Positive in Mid-Stage Study
7/10/2009
More...
|
Rigel Pharmaceuticals, Inc. (RIGL)'s R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial Expected and Manageable Safety Profile Demonstrated in TASKi2
7/10/2009
More...
|
mTOR, Rapamycin, and Lifespan: A Startling Study
7/10/2009
More...
|
Amgen (AMGN) Says Denosumab is More Effective than Novartis Corporation (NVS)' Blockbuster Zometa
7/9/2009
More...
|
Pfizer Inc. (PFE)'s Sutent Fails in Colon Cancer, Trial Halted
7/1/2009
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Pain Drug Meets Late-Stage Study Main Goal
6/25/2009
More...
|
Medarex, Inc. (MEDX) Prostate Cancer Drug Shows Promise
6/24/2009
More...
|
Osiris Therapeutics, Inc. (OSIR) Reports Interim Data for COPD Stem Cell Study; Drug Fails to Improve Lung Function
6/24/2009
More...
|
Cephalon, Inc. (CEPH) Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia; No Increased Benefit in Overall Survival
6/19/2009
More...
|
Alnylam Pharmaceuticals (ALNY), Cubist Pharmaceuticals, Inc. (CBST) Say Respiratory Drug Meets Main Goal
6/9/2009
More...
|
Merck & Co., Inc. (MRK) (JOBS) Heart Failure Drug Misses Goals in Study
6/8/2009
More...
|
Exelixis, Inc. (EXEL) and Bristol-Myers Squibb Company (BMY) (JOBS) Report Phase 2 Data for XL184 in Patients with Previously Treated Glioblastoma Multiforme; Results Not up Expectations
6/3/2009
More...
|
Eli Lilly and Company (LLY) Starts Big Studies for Alzheimer's Candidate
5/26/2009
More...
|
Novartis AG (JOBS) Eyes Blockbuster Sales for New Lung Drug
5/22/2009
More...
|
Eli Lilly and Company (LLY): Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
5/21/2009
More...
|
Exelixis, Inc. (EXEL) Drug Shows Promise in Brain Cancer-Study
5/15/2009
More...
|
Roche (RHHBY)'s (JOBS) Avastin Shows Promise in Early Brain Cancer-Study
5/15/2009
More...
|
AstraZeneca PLC (AZN) Shares Leap After Its Drug Beats Plavix in Test
5/11/2009
More...
|
Schering-Plough Corporation (SGP) Hepatitis C Drug Shines, But Anemia Seen; Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
4/23/2009
More...
|
Roche Holding AG (RHHBF.PK)'s Avastin Misses Goal in Phase III Colon-Cancer Study
4/22/2009
More...
|
Infinity Pharmaceuticals, Inc. Halts Phase III RING Trial in Advanced Gastrointestinal Stromal Tumors
4/15/2009
More...
|
Dendreon Corporation (DNDN) Stocks Soar; PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
4/14/2009
More...
|
Gilead Sciences, Inc. (GILD) Phase III Clinical Trial of Darusentan for Resistant Hypertension Meets Primary Endpoints
4/3/2009
More...
|
Elan Corporation PLC (ELN) and Wyeth (WYE) Drop Top Alzheimer's Drug Dose; Companies to Amend Bapineuzumab Phase 3 Protocols
4/2/2009
More...
|
Orexo AB Announces Phase IIa Data on OX914 in Rhinitis; OX914 Did Not Show a Statistically Significant Reduction in Patient Symptom Scores After Allergen Provocation
3/24/2009
More...
|
Cytos Biotechnology AG Vaccine Fails Mid-stage Trial, Suspends Phase IIb Study and Plans to Reduce Workforce by 40 Percent
3/17/2009
More...
|
Cephalon, Inc. (CEPH) Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
3/17/2009
More...
|
Pfizer Inc. (PFE) (JOBS) Cancer Drug Shows Benefits, Study Halted Early
3/12/2009
More...
|
Genentech, Inc. (DNA) (JOBS), Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) Say Rituxan Fails in Lupus Study
3/12/2009
More...
|
ViroPharma Incorporated (VPHM) Stops Antiviral Drug Late-Stage Study
2/17/2009
More...
|
Vical Incorporated (VICL) (JOBS) Reports Positive Bird Flu Vaccine Trial Data
2/13/2009
More...
|
Amgen (AMGN) (JOBS) Says Motesanib Lung Cancer Trial to Resume
2/12/2009
More...
|
La Jolla Pharmaceutical Company (LJPC) and BioMarin Pharmaceutical Inc. (BMRN) (JOBS) Stop Developing Lupus Drug
2/12/2009
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant
2/3/2009
More...
|
InterMune, Inc. (ITMN) Lung Drug Meets Goal in Trial, Shares Rise +36% on Tuesday at Market Close
2/3/2009
More...
|
Genentech, Inc. (DNA) Updates Colon Cancer Trial Timeline
1/21/2009
More...
|
ReNeuron To Launch Pioneering Stem Cell Trial
1/20/2009
More...
|
Novartis Corporation (NVS)'s RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
1/14/2009
More...
|
Elan Corporation PLC (ELN) Clarifies Duration of Bapineuzumab Phase 3 Trials
1/13/2009
More...
|
Orexigen Therapeutics, Inc. (OREX) Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
1/9/2009
More...
|
US FDA Questions Eli Lilly and Company (LLY) (JOBS), Amgen (AMGN) (JOBS) Cancer Drug Trials
12/12/2008
More...
|
Arena Pharmaceuticals, Inc. (ARNA) Ends Development of Insomnia Drug
12/10/2008
More...
|
Alexza Pharmaceuticals, Inc. (ALXA) Says Trial for Acute Agitation Meets Goal
12/10/2008
More...
|
AstraZeneca PLC (AZN) (JOBS), Targacept, Inc. (TRGT) Say Schizophrenia Trial Fails
12/9/2008
More...
|
Forest Laboratories, Inc. (FRX) and Cypress Bioscience Inc. (CYPB) Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
12/8/2008
More...
|
Amgen (AMGN) (JOBS), Takeda (JOBS), and Millennium (JOBS) Suspend Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer; Drug Test Stopped After Deaths
11/20/2008
More...
|
United Therapeutics Corporation (UTHR) Oral PAH Drug Fails Trial
11/17/2008
More...
|
AstraZeneca PLC (AZN) Release: Statin Reduces Heart Attack, Stroke Rates in Patients With Normal Cholesterol but Elevated C-Reactive Protein
11/11/2008
More...
|
Tarceva Meets Goal In Phase III Study (SATURN) for Advanced Non-Small Cell Lung Cancer; Roche (RHHBY) (JOBS) to Continue Development Program with OSI Pharmaceuticals, Inc. (OSIP) (JOBS) and Genentech, Inc. (DNA) (JOBS)
11/7/2008
More...
|
Schering-Plough Corporation (SGP) Says Hepatitis C Data Positive
11/3/2008
More...
|
Impressive Vertex Pharmaceuticals Incorporated (VRTX) Hepatitis C Drug Data Unveiled
11/3/2008
More...
|
Avigen, Inc. (AVGN)'s Spasticity Drug Fails in Trial, Shares Tank
10/21/2008
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) (JOBS) Announces Positive 28-Day Results for VX-770, an Oral Investigational Agent That Targets a Defective Protein Responsible for Cystic Fibrosis
10/20/2008
More...
|
Cell Genesys, Inc. (CEGE) Slashes 75% of Work Force After Ending Study
10/16/2008
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) To Discontinue Rheumatoid Arthritis Drug As Drug Fails To Meet Primary, Secondary Endpoints
10/10/2008
More...
|
Dendreon Corporation (DNDN)'s Provenge Cuts Death Risk, Shares Soar
10/6/2008
More...
|
Merck & Co., Inc. (MRK) (JOBS) Discontinues Development of Investigational Medicine Taranabant for Obesity
10/2/2008
More...
|
Recent University of Heidelberg Research Shows Significant Benefits In Acute Ischaemic Stroke With Actilyse(R) Beyond Currently FDA Approved Three Hour Treatment Window
9/25/2008
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB), Elan Corporation PLC (ELN) (JOBS) MS Drug Improves Function Over 2 Years
9/22/2008
More...
|
Johnson & Johnson (JNJ) (JOBS) Psoriasis Drug Beats Top-Seller Enbrel in Trial
9/18/2008
More...
|
Amgen (AMGN) (JOBS) Bone Drug Reduces Spine Fracture Risk 68%
9/16/2008
More...
|
NicOx SA (NCOX.F) Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
9/15/2008
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) and Bayer HealthCare AG (BAY) Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
8/19/2008
More...
|
WSJ Questions Boston Scientific Corporation (BSX) Stent Data
8/14/2008
More...
|
Breakthrough Drug Rember 'Could Halt' Alzheimer's, Aberdeen University and TauRx Therapeutics Research
7/30/2008
More...
|
Elan Corporation PLC (ELN) and Wyeth (WYE) Shares Skid as Bapineuzumab Data Leaves Analysts Less Optimistic About Approval
7/30/2008
More...
|
MethylGene and Celgene (CELG) Announce Precautionary Suspension of New Enrollments Into MGCD0103 Clinical Trials
7/23/2008
More...
|
Merck & Co., Inc. (MRK), Schering-Plough Corporation (SGP)'s Vytorin Fails to Meet Main Goal of Heart Study
7/21/2008
More...
|
National Institute of Allergy And Infectious Diseases (NIAID) Will Not Move Forward with the PAVE 100 HIV Vaccine Trial
7/18/2008
More...
|
Insmed Incorporated (INSM) Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
7/10/2008
More...
|
FDA (JOBS) Lifts Clinical Hold on Adolor Corporation (ADLR) Bowel Drug
7/3/2008
More...
|
Elan Corporation PLC (ELN) and Wyeth (WYE) Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease; Drug Works For Some Patients
6/17/2008
More...
|
Celgene International Sárl (CELG) Release: New Analysis of Phase III Studies Shows That REVLIMID(R) Plus Dexamethasone Yielded an Estimated Mean Survival of 5.6 Life Years for Patients with Multiple Myeloma
6/16/2008
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
6/12/2008
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Diabetes Drug Lowers Blood Sugar in Trials
6/9/2008
More...
|
Infinity Pharmaceuticals, Inc. Announces Clinical Data Confirming Activity and Safety of IPI-504, a Novel Hsp90 Inhibitor, in Patients With Refractory GIST
6/2/2008
More...
|
ImClone Systems Incorporated (IMCL) Says Its Cancer Drug Works as Initial Treatment
6/2/2008
More...
|
Sanofi-Aventis (France) (SASY.PA) and Regeneron Pharmaceuticals, Inc. (REGN) Cancer Drug Misses Study Goal
5/21/2008
More...
|
Amgen (AMGN) Release: Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
5/20/2008
More...
|
Genentech, Inc. (DNA)'s Avastin Passes Key Safety Test; Company Moves Up Timeline For Avastin Trial
5/16/2008
More...
|
Amgen (AMGN) Drug AMG-102 Has Little Impact On Brain Cancer
5/16/2008
More...
|
Pharmasset, Inc. (VRUS) Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
5/14/2008
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) Announces Positive Interim Results with Telaprevir-based Therapy in Genotype 1 Chronic Hepatitis C Patients
4/24/2008
More...
|
Genentech, Inc. (DNA)'s AVAiL Phase III Study Fails To Demonstrate Statistically Significant Prolongation Of Overall Survival In Patients With NSCLC
4/21/2008
More...
|
Elan Corporation PLC (ELN), Wyeth (WYE) Suspend Alzheimer's Vaccine Study
4/18/2008
More...
|
ViroPharma Incorporated (VPHM) and Wyeth Pharmaceuticals End Development of Hepatitis C Drug
4/17/2008
More...
|
Genentech, Inc. (DNA) and Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Top-Line Results from a Phase II/III Clinical Trial of Rituxan in Primary-Progressive Multiple Sclerosis; Study Does Not Meet Primary Endpoint
4/15/2008
More...
|
Cutting Dosage of Costly Drug Spurs a Debate
3/17/2008
More...
|
GlaxoSmithKline (GSK)'s Bosatria Shows Promise In Late-Stage Study
3/17/2008
More...
|
deCODE genetics, Inc. (DCGN) Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
3/17/2008
More...
|
Diamyd, Inc. Gets Authorization to Begin Phase III Study in the US
3/14/2008
More...
|
Researchers Develop A Method To Select Eggs With The Best Chance Of Leading To Successful Pregnancy, Université Laval Study
3/13/2008
More...
|
Wyeth (WYE), Progenics Pharmaceuticals, Inc. (PGNX) Bowel Drug Fails in Study
3/12/2008
More...
|
Dendreon Corporation (DNDN) Says Provenge Trial Design Amended to Speed Results
3/12/2008
More...
|
Antigenics Inc. (New York) (AGEN) Cancer Vaccine Study Shows Mixed Results
2/20/2008
More...
|
Dendreon Corporation (DNDN) Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
2/14/2008
More...
|
Genentech, Inc. (DNA) Avado Phase III Study Of Avastin For Breast Cancer Meets Endpoint
2/13/2008
More...
|
Valeant Pharmaceuticals International (VRX) Says Epilepsy Drug Effective in Trial
2/12/2008
More...
|
Acorda Therapeutics (ACOR) Soars on Trial Results; Company Announces Successful Thorough QT Study of Fampridine-SR
1/28/2008
More...
|
Beating Animal Heart Grown From Transplanted Cells in University of Minnesota Study
1/14/2008
More...
|
Cadence Pharmaceuticals, Inc.'s Drug Fails Pain Trial, Shares Plunge
1/11/2008
More...
|
Positive Results from deCODE genetics, Inc. (DCGN) Phase IIa Study
1/9/2008
More...
|
Pharmasset, Inc. (VRUS) Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
1/7/2008
More...
|
QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM)
1/3/2008
More...
|
Savient Pharmaceuticals, Inc. (SVNT) Says Gout Drug Reaches Main Goal in Late-Stage Trial; Stocks Rise
12/13/2007
More...
|
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R)
12/10/2007
More...
|
Celgene International Sárl (CELG) REVLIMID(R) (Lenalidomide) Plus Low-Dose Dexamethasone Achieves Unprecedented Survival Rate in ECOG Phase III Trial in Newly Diagnosed Multiple Myeloma
12/10/2007
More...
|
Metamatics Changes Name to Torrey Path
12/10/2007
More...
|
Pain Therapeutics (PTIE) Remoxy Meets Primary Endpoint in Pivotal Phase III Study
12/6/2007
More...
|
Genentech, Inc. (DNA)'s Avastin Fails Survival, Has Fatal Effects
12/3/2007
More...
|
Roche (RHHBY) Avastin Misses Endpoint in Pancreatic Cancer Study
11/13/2007
More...
|
Shire Pharmaceuticals Group plc (SHPGY)'s Fosrenol Does Not Meet Main Goal of Trial
11/6/2007
More...
|
Gilead Sciences, Inc. (GILD) Hepatitis Drug May Have Heart Issue-Study
11/5/2007
More...
|
Novacea, Inc. (NOVC) (Jobs) Halts Late-Stage Trial of Prostate Cancer Drug Asentar
11/5/2007
More...
|
Hep C Rivals Nip at Vertex Pharmaceuticals Incorporated (VRTX)
11/5/2007
More...
|
Roche (RHHBY)'s Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C
11/2/2007
More...
|
PDL BioPharma, Inc. (PDLI) Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
10/12/2007
More...
|
Affymax, Inc. (AFFY) Doses First Patient in the Phase 3 Clinical Program of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients
10/11/2007
More...
|
Momenta Pharmaceuticals, Inc. (MNTA) Initiates Phase 2 Study of Novel Anticoagulant M118
10/11/2007
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Cancer Injection Study Fails to Meet Main Goal
10/1/2007
More...
|
Pharmasset, Inc. (VRUS) Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
10/1/2007
More...
|